PuraMed BioScience Inc. is readying a media campaign to promote its LipiGesic M homeopathic migraine headache pain reliever.

PuraMed BioScience, LipiGesic M, migraine headache, pain reliever, media blitz, media campaign, advertising campaign, Denver, National Association of Chain Drug Stores, Marketplace 2012, NACDS Marketplace, Russ Mitchell, CVS/pharmacy, Walgreens

Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

PuraMed plans media blitz for LipiGesic M

June 13th, 2012

SCHOFIELD, Wis. – PuraMed BioScience Inc. is readying a media campaign to promote its LipiGesic M homeopathic migraine headache pain reliever.

PuraMed said Tuesday that the multimedia and in-store effort will coincide with the National Association of Chain Drug Stores Marketplace 2012 trade show, which runs June 23 to 26 in Denver.

Calling the initiative its most extensive advertising campaign to date, PuraMed said the eight-week media push will include newspaper, radio, television and in-store video displays. Plans call for the campaign to begin in Denver and extend to other areas in the region such as Colorado Springs, Colo.; Cheyenne, Wyo.; and Albuquerque, N.M.

"We are testing this type of 'media blitz' advertising in the Denver region to see if it can be then be used as a model to carry forward into other urban centers across the US," stated Russ Mitchell, president and chief executive officer of PuraMed BioScience. "We have been working with our retail partner and have devoted resources to help them educate their pharmacists and their consumers about LipiGesic M."

The core message of the ad blitz — which will include real-life testimonials and presentations by medical spokespersons — will be the effectiveness, speed and unique delivery system of LipiGesic M, according to PuraMed. The product is a natural, homeopathic gel that is administered under the tongue.

PuraMed noted that attendance at NACDS Marketplace will give it the opportunity to introduce LipiGesic M to more than 230 retail companies representing over 145,000 retail outlets. "We have already scheduled over 30 appointments with key wholesalers and retailers from all across the company," noted Mitchell.

"Now that we have established national distribution with our main retail partners, it is time to expand our distribution," he added. "The NACDS Marketplace 2012 is the best place to begin this process. There is no other trade event where we can get our clinically tested Migraine treatment product in front of this many distribution opportunities at one time."

To promote LipiGesic M to the medical community, PuraMed has sent sample kits to about 120 health professionals in the Denver region who have requested LipiGesic M samples.

"We timed this incentive to coincide with the NACDS convention so that if any attendees should visit stores in the region, they would see how our existing retail partners market our product," commented Mitchell.

PuraMed announced in January that LipiGesic M hit shelves in CVS/pharmacy's more than 7,300 drug stores. The product became available at Walgreens' 7,800-plus stores in late November.